Latest News - Lindis Initiates Clinical EU Certification Study REMOVE with CATUVAB®
A Targeted Approach
Blood Transfusions (BT) are necessary when a patient loses more than 0.5 liters of blood.and the haematocrit becomes low in a surgical procedure. Intraoperative Blood Salvage (IBS) is a technique frequently used during surgeries that have
A Targeted Approach
Blood Transfusions (BT) are necessary when a patient loses more than 0.5 liters of blood.and the haematocrit becomes low in a surgical procedure. Intraoperative Blood Salvage (IBS) is a technique frequently used during surgeries that have
Location: Germany, Brandenburg, Hennigsdorf
Total raised: $5.56M
Investors 2
| Date | Name | Website |
| - | BFB Brande... | brandenbur... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.12.2019 | - | $5.56M | - |
Mentions in press and media 10
| Date | Title | Description |
| 13.12.2024 | Lindis Blood Care Raises Financing | Lindis Blood Care, a Hennigsdorf, Germany-based medical device company, raised an undisclosed amount in funding. The round was eldby Brandenburg Kapital. High-Tech Gründerfonds, existing and new private investors as well as the founders, Dr... |
| 26.09.2024 | SeedBlink and Lindis Blood Care Invite to an Extended Presentation Event | Another edition of SeedBlink’s Fire Pitch of the Week will take place on September 30th As usual, the pitching event will take place online via Zoom The pitching startup of the day is Lindis Blood Care On September 30th, the famed Romanian ... |
| 10.01.2024 | Brandenburg Kapital - News about Lindis Blood Care GmbH | Hennigsdorf – January 2024. The Lindis Blood Care GmbH announced in December 2023 that the last patient in the clinical study REMOVE has also been treated successfully with CATUVAB®. The medical technology company aims to set a new standard... |
| 10.02.2022 | Lindis Blood Care successfully closes follow-on financing round | February 9, 2022 |
| 09.02.2022 | Lindis Blood Care successfully closes follow-on financing round | Hennigsdorf, Germany – 9th February, 2022. |
| 09.02.2022 | Lindis Blood Care successfully closes follow-on financing round | DGAP-News: Lindis Blood Care GmbH / Key word(s): Financing Lindis Blood Care successfully closes follow-on financing round 09.02.2022 / 10:00 The issuer is solely responsible for the content of this announcement. Lindis Blood Care successfu... |
| 10.11.2021 | Lindis Blood Care Announces Publication of Clinical Pilot Study Results Successfully Highlighting the Potential of CATUVAB(R) in the Removal of Tumor Cells from Surgical Blood in Peer-Reviewed Journal | DGAP-News: Lindis Blood Care GmbH / Key word(s): Study results Lindis Blood Care Announces Publication of Clinical Pilot Study Results Successfully Highlighting the Potential of CATUVAB(R) in the Removal of Tumor Cells from Surgical Blood i... |
| 13.12.2019 | Lindis Bloodcare Raises Over €5M in Total Funding | Lindis Bloodcare, a Hennigsdorf, Germany-based company developing a medical device to be used in oncology for the operation of tumours, raised over €5m in funding. Backers included: – High-Tech Gründerfonds (HTGF), – Brandenburg Kapital, – ... |
| - | Over 5 Million Euros For Lindis Blood Care: Development Of A New Product For The Removal Of Tumor Cells From Surgical Blood | |
| - | Brandenburg Kapital - News about Lindis Blood Care GmbH | Henningsdorf/Berlin - Dec. 2021. Lindis Blood Care, a portfolio company of Brandenburg Kapital that aims to revolutionize blood management during cancer surgeries with its medical device CATUVAB® for the removal of tumor cells from surgical... |